The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02477748. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a multi-center, randomized, double-blind, placebo-controlled, phase 3 study of MDX (1400 mg daily) for 10 weeks compared with placebo in adults with ADHD. The study will be comprised of Screening, Washout (if required), Treatment (total of 10 weeks) and Follow-up periods. Approximately 750 patients will be enrolled and undergo initial eligibility assessments.
Study identification
- NCT ID
- NCT02477748
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 283 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2015 (Type not available)
- Primary completion
- Jan 2017 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Jan 19, 2017
2015 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 26
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex, Inc. | Dothan | Alabama | 36303 | — |
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute | Newport Beach | California | 92660 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| MCB Clinical Research Centers | Colorado Springs | Colorado | 80910 | — |
| Connecticut Clinical Research | Cromwell | Connecticut | 06416 | — |
| Coastal Connecticut Research | New London | Connecticut | 06320 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Clinical Neuroscience Solutions | Jacksonville | Florida | 32256 | — |
| CNS Healthcare | Orlando | Florida | 32801 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Institute for Advanced Medical Research | Alpharetta | Georgia | 30005 | — |
| Goldpoint Clinical Research | Indianapolis | Indiana | 46260 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| Kennedy Krieger Institute | Baltimore | Maryland | 21205 | — |
| Rochester Center For Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| St. Charles Psychiatric Associates - Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Premier Psychiatric Research Institute | Lincoln | Nebraska | 68526 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| Global Medical Institutes, LLC, Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| The Medical Research Network | New York | New York | 10128 | — |
| Richard H Weisler, MD, PA | Raleigh | North Carolina | 27609 | — |
| Neuro-Behavioral Clinical Research, Inc. | Canton | Ohio | 44718 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Village Clinical Research Inc | Oklahoma City | Oklahoma | 73103 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Carolina Clinical Research, Inc. | Charleston | South Carolina | 29405 | — |
| Clinical Neuroscience Solutions | Memphis | Tennessee | 38119 | — |
| BioBehavioral Research of Austin at Specialty Clinic of Austin | Austin | Texas | 78759 | — |
| Bayou City Research | Houston | Texas | 77007 | — |
| Psychiatric & Behavioral Solutions | Salt Lake City | Utah | 84105 | — |
| NeuroScience, Inc. (NSI) | Herndon | Virginia | 20170 | — |
| Summit Research Network(Seattle)LLC | Seattle | Washington | 98104 | — |
| Dean Foundation - Middleton | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02477748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2017 · Synced Nov 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.